The Honest Company, Inc. (HNST) is a Los Angeles–based personal care company selling cleanly formulated diapers, wipes, baby care, beauty and household products through major retailers and e-commerce channels. In Thursday's session, the shares were trading at $4.52, down 5.24% from the prior session's close of $4.77 — a decline of $0.25 per share that left the stock near the lower end of its intraday range. The direction was unambiguously negative. No company announcement, regulatory filing, or new Wall Street rating change was identified that accounts for the move, and the decline instead extends a week-long retreat that has now erased the entire post-earnings advance the stock built in early November.
No verified news or fundamental catalyst found for Thursday's decline. The most plausible explanation is that investors are taking profits after a sharp, news-driven run higher earlier in the month, a pattern consistent with the stock's recent behavior.
The company reported third-quarter results on November 5, and those numbers were strong: organic revenue rose 9.2%, underlying adjusted gross margin reached 48.9% and underlying adjusted EBITDA came in at $6.3 million, alongside a raised full-year revenue and EBITDA outlook and a new $30 million share repurchase authorization. The shares responded by climbing roughly 17% over the next three sessions, from $4.44 to $5.20 by November 10. That advance has since unwound almost completely, and at $4.52 the stock trades only slightly above its pre-earnings close.
Two secondary factors sit in the background rather than at the center of the move. First, a routine notice of proposed officer share sales was filed in early November, and the stock has seen a steady drip of insider selling since late summer. At roughly 25,000 shares per transaction, those sales are far too small to move a company worth about $490 million. Second, trading liquidity has thinned: daily turnover in the past two weeks has run between roughly 1.0 million and 1.6 million shares, well below the three-month average near 2.1 million. A thinner order book increases the price impact of ordinary selling, which is consistent with an outsized percentage decline on a day with no identifiable news.
The pullback was company-specific rather than part of an identifiable sector-wide repricing; no sector headline or scheduled macro release mapped cleanly onto the timing. The decline pushed the shares below their 50-day moving average near $5.00 and back toward the lower boundary of a range that has held since late October. The stock's beta of about 2.47, combined with a modest float and light recent turnover, means it amplifies broader moves in either direction. Its 52-week range of $2.07 to $6.01 underscores how wide the trading band has been, even as the shares remain up roughly 80% year to date.
The score runs on a scale where 0 means no meaningful news and a move that is routine for the stock, while 100 means transformative news paired with an extreme and rare price move. This event scores 14 out of 100. The fundamental side is weak: no fresh company disclosure, analyst action or material development was verified, leaving only background items such as recent insider sales and a holiday-quarter narrative still in progress.
The price side is also moderate. Thursday's 5.24% decline is roughly 1.9 times the stock's average absolute daily move of about 2.8% over the past 74 sessions, and three sessions in the last 60 had equal or larger moves, including a 10.7% jump on November 9. With neither component strong, the two combine into a low overall score.
The next scheduled test is the fourth-quarter and full-year 2026 report, expected in late February or early March, which will cover the critical holiday period. Before then, investors will track third-party consumption data for wipes and personal care — the categories now driving organic growth — against continued declines in diapers and the impact of previously exited product lines. Gross margin sustainability is central: management raised its full-year revenue outlook to $322–$325 million and lifted EBITDA guidance on the back of record underlying margins. Execution of the $30 million buyback and cash generation from a balance sheet holding roughly $103 million in cash are additional watch items. The sell side remains divided, with ratings clustered around Hold and recent price-target reductions following the quarter. Key risks include promotional intensity in diapers, input and tariff costs, and the possibility that consumption growth fails to keep pace with revenue expectations.
Tickeron's Trending AI Robots page highlights a curated selection from a much larger library of hundreds of AI trading bots covering thousands of tickers. Rather than listing the full catalog, it surfaces only the bots posting the strongest results under current market conditions. Strategies vary widely by timeframe, approach, performance metrics and the symbols they trade, so the featured group rotates as market leadership shifts. Investors looking for systematic, rules-based exposure may find it a useful starting point for further review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where HNST declined for three days, in 264 of 305 cases, the price declined further within the following month. The odds of a continued downward trend are 87%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 53 cases where HNST's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
HNST moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.
HNST broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HNST entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HNST's RSI Oscillator exited the oversold zone, 31 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on HNST as a result. In 71 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for HNST just turned positive on November 09, 2026. Looking at past instances where HNST's MACD turned positive, the stock continued to rise in 36 of 49 cases over the following month. The odds of a continued upward trend are 73%.
Following a +11.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where HNST advanced for three days, in 172 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.000) is normal, around the industry mean (21.731). HNST has a moderately low P/E Ratio (-46.700) as compared to the industry average of (16.288). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.518). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (1.750) is also within normal values, averaging (1.902).
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. HNST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HNST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry HouseholdPersonalCare